Spots Global Cancer Trial Database for Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer
Official Title: Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer
Study ID: NCT04137822
Interventions
Study Description
Brief Summary: An Expanded Access Program for IMM-101 for patients with advanced pancreatic cancer.
Detailed Description: IMM-101 is a suspension of heat-killed whole cell Mycobacterium obuense. Since it is a heat-killed preparation, treatment is not associated with the potential side-effects of delivering live or attenuated organisms. Five studies with IMM-101 have been completed including a 110-patient randomised Phase II study in pancreatic cancer and exploratory studies in other solid tumours (melanoma, colorectal cancer and advanced melanoma).
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
France, Paris, , France
UK, London, , United Kingdom
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
